GSKCONS

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Intimation of Record Date and Effective Date for Scheme of Amalgamation by way of merger by absorption among GlaxoSmithKline Consumer Healthcare Limited and Hindustan Unilever Limited and their respective shareholders and creditors.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that Register of Members and Share Transfer Book of the Company will remain closed from Saturday, July 27, 2019 to Friday, August 2, 2019 (both days inclusive) for the purpose of 60th Annual General Meeting and for taking on record the Shareholders for the purpose of payment of Dividend, if approved at the Annual General Meeting, for the year ended March 31, 2019.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that the Company has fixed Book Closure from July 27, 2019 to August 2, 2019 for the purpose of AGM and Dividend

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that the Register of Members and Share Transfer Books of the Company will remain closed from July 27, 2019 to August 2, 2019, (both days inclusive) for the purpose of Dividend and Annual General Meeting.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that the Register of Members and Share Transfer Books of the Company shall remain closed from August 2, 2018 to August 8, 2018(both days inclusive) for the purpose of dividend and Annual General Meeting of the Company is scheduled to be held on August 08, 2018.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that the Register of Members & Share Transfer Books of the Company will remain closed from August 4, 2017 to August 9, 2017 for the purpose of Dividend and Annual General Meeting.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that the Register of Members & Share Transfer Books of the Company will remain closed from July 28, 2016 to August 5, 2016 (both days inclusive) for the purpose of Dividend and Annual General Meeting (AGM) of the Company to be held on August 5, 2016.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that the Register of Members & Share Transfer Books of the Company will remain closed from July 29, 2015 to August 6, 2015 (both days inclusive) for the purpose of dividend and Annual General Meeting (AGM) of the Company to be held on August 6, 2015.

GlaxoSmithKline Consumer Healthcare Limited had informed the Exchange that the Company has fixed Book Closure from July 29, 2014 to August 7, 2014 for the purpose of Payment of Dividend & Annual General Meeting of the Company to be held on August 07, 2014. The Company has now informed the Exchange that as July 29, 2014 is a holiday, the date of Book closure is being revised. The Company has fixed revised Book Closure from July 31, 2014 to August 7, 2014 (both days inclusive) for the purpose of dividend and AGM.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that the Company has fixed Book Closure from July 29, 2014 to August 7, 2014 for the purpose of Payment of Dividend & Annual General Meeting of the Company to be held on August 07, 2014.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that the Company has fixed Book Closure from March 21, 2013 to April 9, 2013 both days inclusive for the purpose of Dividend and the Annual General Meeting

HSBC Securities and Capital Markets (India) Private Limited has informed the Exchange regarding Voluntary Open Offer by GlaxoSmithKline Pte Ltd ("GSK Pte" or t he "Acquirer") along with Horlicks Limited ("Horlicks") and GlaxoSmithKline plc ("GSK plc") in their capacity as persons acting in concert (each entity individu ally referred to as "PAC" and together referred to as "PACs") with the Acquirer, to the equity shareholders of GlaxoSmithKline Consumer Healthcare Limited (the "Target Company") to acquire 13,389,410 equity shares ("Shares) of Rs. 10/- each representing 31.84% of the total Vo

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Register of Members and Share Transfer Books will remain closed from March 13, 2012 to March 22, 2012, both days inclusive, for the purpose of Dividend and the Annual General Meeting scheduled to be held on March 22, 2012.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Register of Members and Share Transfer Books will remain closed from March 15, 2011 to March 28, 2011, both days inclusive, for the purpose of Dividend and Annual General Meeting. Further, the Annual General Meeting of the members of the Company will be held on March 29, 2011.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Register of Members and Share Transfer Books will remain closed from April 16, 2009 to April 24, 2009, both days inclusive, for the purpose of Dividend and Annual General Meeting. Further, the Annual General Meeting of the members of the Company will be held on April 24, 2009.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Register of Members of the Company shall remain closed from April 17, 2008 to April 24, 2008 (both days inclusive) for taking on record the shareholders for the purpose of the Annual General Meeting of the equity shareholders scheduled to be held on April 25, 2008.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Register of Members of the Company shall remain closed from April 18, 2007 to April 26, 2007 (both days inclusive) for taking on record the shareholders for the purpose of the Annual General Meeting of the equity shareholders scheduled to be held on April 27, 2007.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Company has fixed November 01, 2006 as the "Record Date" for the purpose of payment of interim dividend, if approved at the Board Meeting. Dividend warrants in respect of the proposed dividend, if declared, will be made payable on or before November 23, 2006.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Register of Members of the Company shall remain closed from April 20, 2006 to April 28, 2006 (both days inclusive) for taking on record the shareholders for the purpose of the AGM of the equity shareholders scheduled to be held on April 29, 2006.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the equity shares of the Company have been delisted from the Calcutta Stock Exchange as confirmed by the Exchange vide their letter dated February 21, 2006 and the name of the Company has been removed as a listed securities from the Official list of the Exchange.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that in pursuance of Regulation 12(1) of the SEBI (Buy-back of Securities) Regulations, 1998, 842 physical share certificates representing 95,918 Equity shares of Rs.10 each of the Company bought back by the Company in response to the Letter of Offer dated March 02, 2005 addressed to all the shareholders of the Company (out of a total of 33,25,083 equity shares bought back by the Company including 32,29,165 equity shares in dematerialised form), were physically destroyed on April 27, 2005. The share capital of the Company st

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Register of Members of the Company shall remain closed from April 21, 2005 to April 28, 2005 (both days inclusive) for taking on record the shareholders for the purpose of the AGM of the equity shareholders scheduled to be held on April 29, 2005.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Buy-back Committee of Directors of the Company, in their meeting held on January 20, 2005, has decided to fix March 01, 2005 as the 'Specified Date' for the purpose of determining the name of the shareholders to whom the Letter of Offer for buying back the equity shares of the company shall be sent.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Buy-back Committee of Directors of the Company, in their meeting held on January 20, 2005, have decided to buy back the equity shares at a price of Rs.370 per equity share.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the BOD's at a meeting held on December 10, 2004 have considered and approved the buy back of the equity shares of the Company upto 33,25,083 fully paid up equity shares of Rs.10/- each, constituting up to 7.33% of the paid-up Equity Share Capital of the Company at a price not exceeding Rs.370/- per equity share and an amount not exceeding Rs.12302.81 Lakhs which constitutes 25% of the Paid up capital and Free Reserves of the Company as on December 31, 2003.

Glaxosmithkline Consumer Healthcare Limited had informed the Exchange that the company has fixed October 29, 2004 as the record date for the purposes of payment of second interim dividend, if approved at the Board Meeting to be held on October 25, 2004. The Company has now informed that the Record Date for the purpose of payment of interim dividend, if approved at the Board Meeting, has been changed to November 02, 2004 instead of October 29, 2004.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Equity shares of the Company have been delisted from the following stock exchanges: (1) The Ludhiana Stock Exchange Assn Limited. (2) The Delhi Stock Exchange Assn Limited w.e.f September 2, 2004. (3) The Madras Stock Exchange Assn Limited w.e.f. August 23, 2004.